THY1 and cancer: In summary, our study uncovers the molecular mechanisms by which cancer cell β3 integrin engagement of Thy-1 in EC triggers cancer cell migration and invasion, and in doing so, identifies various candidates that could be targeted to treat cancer patients, perhaps in a combined multiple-target therapy.